Key Takeaways
- SMR stock climbed 14.7% during Wednesday’s session, reaching approximately $11.76, followed by an additional 5% increase after hours.
- A UK government initiative aimed at advancing small modular reactor technology sparked the nuclear sector rally.
- RBC’s Chris Dendrinos maintains a Sector Perform rating with a $14 target, cautioning investors about near-term momentum chasing.
- Ongoing class-action lawsuits related to ENTRA1 disclosures continue to pose material risks, with April 20 marking the lead-plaintiff motion deadline.
- Company insiders have disposed of more than 14 million shares valued at approximately $171M over the past three months, including a major 13.5 million share sale by a director.
Shares of NuScale Power experienced a substantial 14.7% rally on Wednesday, briefly touching $12.02 before closing near $11.76. The momentum extended beyond regular trading hours with an additional 5% advance. Trading volume surged to approximately 57.5 million shares, representing a 119% increase above typical daily activity.
NuScale Power Corporation, SMR
The primary driver behind the surge was a UK government financing initiative aimed at accelerating the deployment of small modular reactor technology. While NuScale isn’t a direct recipient of these funds, the announcement generated positive sentiment throughout the nuclear energy sector. Market participants interpreted the move as evidence of growing governmental commitment to supporting innovative nuclear energy solutions.
Broader equity market conditions also contributed to the advance. Recent improvements in risk appetite have renewed investor interest in longer-duration growth narratives like NuScale. The company operates at the intersection of multiple compelling themes — energy independence, carbon reduction goals, and escalating power requirements for AI data centers — a convergence increasingly resonating with market participants.
Additional momentum came from a Rolls-Royce SMR contract announcement, which created a tailwind for US-listed small modular reactor companies across the board. NuScale captured benefits from both the improved sector sentiment and probable short position covering.
Analyst Maintains Conservative Stance
Chris Dendrinos of RBC Capital Markets remains measured in his outlook. While acknowledging that NuScale is “headed in the right direction with incremental progress,” he emphasizes that the pathway to achieving a Final Investment Decision (FID) remains “lengthy.” His Sector Perform rating continues unchanged, and he recently adjusted his price target while elevating discount rate assumptions to account for execution uncertainty.
Dendrinos highlights that NuScale’s success trajectory depends substantially on variables beyond management control — particularly regulatory approvals and external project financing. Protracted development timelines increase the probability of equity dilution events and complicate valuation modeling. While his $14 price target suggests approximately 20% appreciation potential from current trading levels, he advises against aggressive positioning at these prices.
Wall Street sentiment remains divided. Current analyst ratings break down to 5 Buy recommendations, 6 Hold positions, and 1 Sell rating — yielding a Moderate Buy consensus — with a mean price target of $17.39, suggesting roughly 48.5% upside potential contingent on improved execution.
Among the more optimistic voices, Bank of America elevated the stock to Neutral with a $28 price objective in January. Texas Capital assigned a Strong Buy rating in late January. Conversely, UBS reduced its target to $13, Canaccord dramatically lowered its forecast from $60 to $25, and Citigroup maintains a Sell rating with an $11.50 target. The consensus estimate settles at $20.96.
Fundamental and Legal Challenges Persist
The company’s underlying financial performance remains troubled. NuScale reported earnings per share of -$0.80 in its most recent quarter, significantly missing the consensus estimate of -$0.10. Revenue totaled just $1.81 million versus analyst expectations of $8.76 million. The net margin currently stands at negative 1,130%.
Insider transactions paint a concerning picture. The chief executive officer disposed of 82,667 shares in early March. A board member sold 13.5 million shares valued at approximately $163 million in April. Combined insider sales over the trailing 90-day period total 14.1 million shares worth $171 million. Current insider ownership has declined to merely 1.2% of outstanding shares.
Active class-action litigation adds another layer of uncertainty. Multiple law firms are pursuing claims connected to alleged ENTRA1 disclosure deficiencies, with April 20 established as the deadline for lead-plaintiff motions. The complaints allege material misrepresentations linked to an earlier stock decline of approximately 12%.
Technical indicators show the 50-day moving average at $12.41, while the 200-day moving average sits at $21.21.
